electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 MillionGlobeNewsWire • 01/20/26
electroCore, Inc. (ECOR) Discusses Neuromodulation Platform, Business Evolution, and Strategic Priorities TranscriptSeeking Alpha • 12/26/25
TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force AirmenGlobeNewsWire • 12/02/25
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumGlobeNewsWire • 11/10/25
electroCore, Inc. (ECOR) Reports Q3 Loss, Beats Revenue EstimatesZacks Investment Research • 11/06/25
Analysts Estimate electroCore, Inc. (ECOR) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 10/29/25
electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025GlobeNewsWire • 10/23/25
gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion SymptomsGlobeNewsWire • 09/30/25
electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in BelgiumGlobeNewsWire • 09/29/25
electroCore's Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire's 2025 Sleep AwardsGlobeNewsWire • 09/22/25
electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the BoardGlobeNewsWire • 09/05/25
electroCore Partners with iHeartRadio and Former New York Jets Star Linebacker Greg Buttle to Champion Better Sleep and Stress ReliefGlobeNewsWire • 09/04/25
electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of TruvagaGlobeNewsWire • 08/12/25
electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025GlobeNewsWire • 07/23/25
ElectroCore, Inc. (ECOR) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/07/25